Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 134 for vascular surgery

Edit search filters
  1. Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus

    Rochester, MN

  2. A Study of the Presence of Viral Pathogens in Culture-Negative, Non-Specific Pleuritis

    Rochester, MN

  3. TX2® Low Profile TAA Endovascular Graft

    Rochester, MN

  4. Assessment of Coronary Plaque Composition

    Rochester, MN

  5. A Study to Analyze if Exercise Echocardiography Can Identify Ventricular and Vascular Function Abnormalities That are Undetectable at Rest for Patients With Coarctation of Aorta (COA)

    Rochester, MN

  6. Feasibility Study of IV rtPA vs. Primary Endovascular Therapy for Acute Ischemic Stroke

    Jacksonville, FL

  7. A Study Comparing Changes in Lung Diffusing Capacity, Cardiac Output, and Pulmonary Vascular Pressures During Exercise in Younger versus Older Individuals

    Rochester, MN

  8. Assessment Of The GORE® EXCLUDER® Conformable AAA Endoprosthesis In The Treatment Of Abdominal Aortic Aneurysms

    Rochester, MN

  9. A Study Of The GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis In The Treatment Of Type IV Thoracoabdominal Aortic Aneurysms Involving The Visceral Branch Vessels

    Rochester, MN

  10. Lp-PLA2, Progenitor Cells and Coronary Atherosclerosis in Humans AIM III

    Rochester, MN, Rochester, MN

.

Mayo Clinic Footer